ERC Consolidator Grant · 2020
Inflammatory bowel disease (IBD) is an incurable, inflammatory condition of the gastrointestinal tract (GIT) that affects millions of patients worldwide and places an enormous economic burden on society. Most alarmingly, children account for one quarter of all IBD cases with steadily increasing incidence. Current clinical practices for IBD diagnosis and therapy are demanding and ineffective in terms of treatment outcome, patient compliance and cost and by far not optimized for children. Our aim is to establish a theranostic platform for diagnosis and personalized treatment of pediatric IBD by an interdisciplinary approach bridging discovery of disease biomarkers, nanomaterial and drug…
From the public funding record at EU CORDIS. Describes the funded project, not the reviews below.